Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hot Temperature | 52 | 2024 | 1440 | 7.920 |
Why?
|
Body Temperature Regulation | 34 | 2024 | 292 | 6.810 |
Why?
|
Sweating | 32 | 2024 | 155 | 5.610 |
Why?
|
Heat Stress Disorders | 17 | 2024 | 80 | 4.140 |
Why?
|
Body Temperature | 25 | 2024 | 781 | 3.510 |
Why?
|
Vasodilation | 20 | 2022 | 962 | 2.310 |
Why?
|
Exercise | 28 | 2024 | 5890 | 2.050 |
Why?
|
Heat-Shock Response | 16 | 2024 | 179 | 1.810 |
Why?
|
Heart Rate | 19 | 2024 | 4195 | 1.770 |
Why?
|
Work | 5 | 2020 | 195 | 1.710 |
Why?
|
Extreme Heat | 3 | 2024 | 58 | 1.690 |
Why?
|
Skin Temperature | 8 | 2023 | 96 | 1.510 |
Why?
|
Skin Physiological Phenomena | 8 | 2019 | 188 | 1.120 |
Why?
|
Cold Temperature | 5 | 2024 | 785 | 1.110 |
Why?
|
Physical Exertion | 7 | 2024 | 667 | 1.110 |
Why?
|
Immersion | 2 | 2024 | 37 | 0.970 |
Why?
|
Occupational Exposure | 6 | 2024 | 1813 | 0.920 |
Why?
|
Sweat | 4 | 2022 | 56 | 0.900 |
Why?
|
Skin | 20 | 2022 | 4484 | 0.850 |
Why?
|
Dehydration | 3 | 2018 | 216 | 0.780 |
Why?
|
Calorimetry | 7 | 2020 | 129 | 0.740 |
Why?
|
Threshold Limit Values | 2 | 2017 | 12 | 0.700 |
Why?
|
NG-Nitroarginine Methyl Ester | 10 | 2022 | 260 | 0.690 |
Why?
|
Humidity | 3 | 2020 | 205 | 0.670 |
Why?
|
Ascorbic Acid | 3 | 2022 | 655 | 0.660 |
Why?
|
Arginase | 1 | 2019 | 80 | 0.630 |
Why?
|
Thermogenesis | 9 | 2023 | 475 | 0.620 |
Why?
|
Aging | 8 | 2024 | 8708 | 0.620 |
Why?
|
Post-Exercise Hypotension | 1 | 2018 | 2 | 0.620 |
Why?
|
Forearm | 8 | 2020 | 427 | 0.620 |
Why?
|
Temperature | 6 | 2024 | 2226 | 0.610 |
Why?
|
Sweat Glands | 3 | 2022 | 33 | 0.610 |
Why?
|
Nitric Oxide Synthase | 9 | 2022 | 908 | 0.590 |
Why?
|
Nitric Oxide | 7 | 2022 | 2135 | 0.560 |
Why?
|
Microdialysis | 2 | 2016 | 161 | 0.550 |
Why?
|
Cardiovascular System | 1 | 2024 | 834 | 0.540 |
Why?
|
Stress, Physiological | 5 | 2024 | 1403 | 0.510 |
Why?
|
Physical Endurance | 1 | 2018 | 366 | 0.500 |
Why?
|
Antioxidants | 3 | 2022 | 1668 | 0.480 |
Why?
|
Regional Blood Flow | 9 | 2020 | 1496 | 0.480 |
Why?
|
Cross-Over Studies | 4 | 2024 | 2078 | 0.470 |
Why?
|
Self Report | 3 | 2024 | 3724 | 0.470 |
Why?
|
Leukocytes, Mononuclear | 5 | 2024 | 1844 | 0.440 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2024 | 12148 | 0.440 |
Why?
|
Hemodynamics | 2 | 2023 | 4159 | 0.390 |
Why?
|
Young Adult | 33 | 2024 | 59243 | 0.380 |
Why?
|
Heart | 2 | 2024 | 4404 | 0.380 |
Why?
|
Methacholine Chloride | 3 | 2016 | 220 | 0.370 |
Why?
|
Oxidative Stress | 3 | 2017 | 3113 | 0.350 |
Why?
|
Foot | 2 | 2024 | 575 | 0.350 |
Why?
|
Male | 65 | 2024 | 360804 | 0.340 |
Why?
|
Neck | 2 | 2024 | 734 | 0.330 |
Why?
|
Autophagy | 5 | 2024 | 1326 | 0.320 |
Why?
|
Autonomic Nervous System | 3 | 2024 | 703 | 0.320 |
Why?
|
Blood Pressure | 6 | 2024 | 8481 | 0.320 |
Why?
|
Environmental Exposure | 1 | 2024 | 4486 | 0.320 |
Why?
|
Adult | 39 | 2024 | 221177 | 0.300 |
Why?
|
Water | 3 | 2024 | 1411 | 0.300 |
Why?
|
Calorimetry, Indirect | 5 | 2020 | 174 | 0.300 |
Why?
|
Rest | 3 | 2024 | 918 | 0.290 |
Why?
|
Ketorolac | 3 | 2018 | 94 | 0.290 |
Why?
|
Muscarinic Agonists | 3 | 2018 | 91 | 0.280 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 3 | 2016 | 318 | 0.260 |
Why?
|
Humans | 77 | 2024 | 761504 | 0.260 |
Why?
|
Baroreflex | 2 | 2024 | 149 | 0.260 |
Why?
|
Heating | 3 | 2020 | 104 | 0.260 |
Why?
|
West Virginia | 2 | 2016 | 31 | 0.260 |
Why?
|
Aged | 27 | 2024 | 169289 | 0.250 |
Why?
|
Middle Aged | 29 | 2024 | 220895 | 0.250 |
Why?
|
Occupational Diseases | 3 | 2024 | 1490 | 0.240 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2015 | 361 | 0.240 |
Why?
|
Age Factors | 6 | 2024 | 18395 | 0.230 |
Why?
|
Texas | 2 | 2016 | 404 | 0.230 |
Why?
|
Drinking | 2 | 2015 | 198 | 0.230 |
Why?
|
Potassium Channels | 2 | 2017 | 537 | 0.230 |
Why?
|
Mining | 1 | 2024 | 93 | 0.220 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 2016 | 477 | 0.220 |
Why?
|
Hypertension | 4 | 2024 | 8540 | 0.220 |
Why?
|
Ontario | 1 | 2024 | 398 | 0.210 |
Why?
|
Enterocytes | 1 | 2024 | 220 | 0.210 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1866 | 0.210 |
Why?
|
Progestins | 1 | 2024 | 301 | 0.200 |
Why?
|
Ouabain | 3 | 2016 | 247 | 0.200 |
Why?
|
Chemoreceptor Cells | 1 | 2021 | 89 | 0.190 |
Why?
|
Bicycling | 3 | 2020 | 177 | 0.190 |
Why?
|
Isometric Contraction | 1 | 2021 | 150 | 0.190 |
Why?
|
Saline Solution, Hypertonic | 1 | 2021 | 114 | 0.190 |
Why?
|
Health Communication | 1 | 2023 | 213 | 0.180 |
Why?
|
Acclimatization | 1 | 2020 | 113 | 0.170 |
Why?
|
Ballistocardiography | 1 | 2019 | 13 | 0.170 |
Why?
|
Potassium Channels, Calcium-Activated | 2 | 2017 | 43 | 0.170 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2019 | 28 | 0.170 |
Why?
|
Receptor, PAR-2 | 1 | 2019 | 33 | 0.170 |
Why?
|
Exercise Test | 4 | 2024 | 2127 | 0.170 |
Why?
|
Female | 30 | 2024 | 392644 | 0.160 |
Why?
|
Sympathetic Nervous System | 1 | 2021 | 518 | 0.160 |
Why?
|
Hyperthermia, Induced | 1 | 2022 | 417 | 0.150 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2017 | 67 | 0.150 |
Why?
|
Rehydration Solutions | 1 | 2017 | 43 | 0.150 |
Why?
|
Pyridoxine | 1 | 2017 | 108 | 0.150 |
Why?
|
Vagus Nerve | 1 | 2020 | 458 | 0.140 |
Why?
|
Administration, Cutaneous | 2 | 2016 | 713 | 0.140 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2016 | 106 | 0.140 |
Why?
|
Time Factors | 6 | 2024 | 39967 | 0.140 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 321 | 0.130 |
Why?
|
Ergometry | 1 | 2015 | 17 | 0.130 |
Why?
|
Atropine | 1 | 2016 | 244 | 0.130 |
Why?
|
Blood Flow Velocity | 2 | 2017 | 1371 | 0.130 |
Why?
|
Muscarinic Antagonists | 1 | 2016 | 135 | 0.120 |
Why?
|
Cardiac Output | 1 | 2018 | 831 | 0.120 |
Why?
|
Individuality | 1 | 2017 | 301 | 0.120 |
Why?
|
Arginine | 1 | 2019 | 934 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1750 | 0.120 |
Why?
|
Protective Clothing | 1 | 2015 | 103 | 0.120 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2015 | 153 | 0.120 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2015 | 517 | 0.110 |
Why?
|
Climate Change | 1 | 2020 | 501 | 0.110 |
Why?
|
Energy Metabolism | 2 | 2021 | 2882 | 0.110 |
Why?
|
Losartan | 1 | 2015 | 265 | 0.110 |
Why?
|
Reflex | 1 | 2015 | 376 | 0.110 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58976 | 0.110 |
Why?
|
Nicotine | 1 | 2018 | 680 | 0.100 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 705 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3826 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2015 | 592 | 0.100 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 431 | 0.100 |
Why?
|
Angiotensin II | 1 | 2015 | 849 | 0.100 |
Why?
|
Enzyme Inhibitors | 6 | 2017 | 3712 | 0.100 |
Why?
|
Workload | 1 | 2018 | 844 | 0.100 |
Why?
|
Esophagus | 1 | 2017 | 1033 | 0.090 |
Why?
|
Perception | 1 | 2016 | 1197 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9318 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10766 | 0.080 |
Why?
|
Sex Factors | 1 | 2023 | 10552 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 1989 | 0.080 |
Why?
|
Canada | 2 | 2024 | 2122 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20098 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1779 | 0.070 |
Why?
|
Equipment Design | 1 | 2016 | 3510 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2141 | 0.070 |
Why?
|
Urine | 2 | 2020 | 362 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4948 | 0.070 |
Why?
|
Injections, Intradermal | 2 | 2016 | 116 | 0.070 |
Why?
|
Bacterial Translocation | 1 | 2024 | 73 | 0.060 |
Why?
|
British Columbia | 1 | 2023 | 241 | 0.050 |
Why?
|
Electrocardiography | 3 | 2020 | 6377 | 0.050 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2024 | 296 | 0.050 |
Why?
|
Osmotic Pressure | 1 | 2021 | 138 | 0.050 |
Why?
|
Specific Gravity | 1 | 2020 | 18 | 0.050 |
Why?
|
Fatigue | 2 | 2018 | 1552 | 0.050 |
Why?
|
Mass Media | 1 | 2023 | 303 | 0.050 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2020 | 239 | 0.040 |
Why?
|
Heat-Shock Proteins | 1 | 2024 | 795 | 0.040 |
Why?
|
Basal Metabolism | 1 | 2020 | 161 | 0.040 |
Why?
|
Photoplethysmography | 1 | 2019 | 60 | 0.040 |
Why?
|
Housing | 1 | 2024 | 670 | 0.040 |
Why?
|
Nitroarginine | 1 | 2018 | 66 | 0.040 |
Why?
|
Workplace | 1 | 2024 | 863 | 0.040 |
Why?
|
Anaerobic Threshold | 1 | 2017 | 51 | 0.040 |
Why?
|
Occupational Health | 1 | 2024 | 806 | 0.040 |
Why?
|
Environmental Monitoring | 1 | 2024 | 1460 | 0.040 |
Why?
|
Barium Compounds | 1 | 2016 | 18 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 2219 | 0.030 |
Why?
|
KATP Channels | 1 | 2017 | 48 | 0.030 |
Why?
|
Water-Electrolyte Balance | 1 | 2017 | 325 | 0.030 |
Why?
|
Bumetanide | 1 | 2016 | 98 | 0.030 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2017 | 141 | 0.030 |
Why?
|
Apoptosis | 2 | 2024 | 9486 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2020 | 579 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3579 | 0.030 |
Why?
|
Rectum | 1 | 2020 | 892 | 0.030 |
Why?
|
Vitamin B Complex | 1 | 2017 | 299 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.030 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 152 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1520 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
Chlorides | 1 | 2016 | 665 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1187 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2024 | 3032 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4352 | 0.030 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2016 | 973 | 0.020 |
Why?
|
Family | 1 | 2022 | 3194 | 0.020 |
Why?
|
Internet | 1 | 2023 | 3092 | 0.020 |
Why?
|
Anthropometry | 1 | 2015 | 1349 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88319 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3250 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1618 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
Child | 2 | 2022 | 80153 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8654 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42230 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80636 | 0.010 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_